Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,447 total articles

LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS

LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS

LIXTE Biotechnology Holdings, Inc. completed its merger with NOMAD Transportable Power Systems, shifting its business focus to deployable, utility-grade battery energy storage systems (BESS). The company changed its name to NOMAD Power Solutions, Inc. and updated its ticker to NMAD. The merger positions the company to capitalize on market opportuni…

Iron Dome Acquisition I Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 6, 2026

Iron Dome Acquisition I Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 6, 2026

Iron Dome Acquisition I Corp. announced that starting July 6, 2026, holders of its IPO Units may separate and trade the Class A ordinary shares and warrants independently on Nasdaq under the tickers IDAC and IDACW, respectively. Units not separated will continue trading as IDACU. The company aims to pursue a business combination in cybersecurity, d…

Cemtrex Completes Acquisition of Plant Engineering Services, Adding Specialized Engineering Capabilities and Expanding into Automotive and Defense Markets

Cemtrex Completes Acquisition of Plant Engineering Services, Adding Specialized Engineering Capabilities and Expanding into Automotive and Defense Markets

Cemtrex, Inc. announced the acquisition of Plant Engineering Services (PES), an engineering firm specializing in hydraulic and mechanical press systems, thereby enhancing its Advanced Industrial Services (AIS) subsidiary's engineering capabilities. The acquisition expands Cemtrex's footprint into automotive and defense markets and allows AIS to off…

Propanc Biopharma Initiates $5.0 Million Share Repurchase Program

Propanc Biopharma Initiates $5.0 Million Share Repurchase Program

Propanc Biopharma, a Nasdaq-listed biopharmaceutical company developing novel cancer treatments, announced the initiation of a $5 million share repurchase program starting with a first tranche of up to $500,000 over 30 days. The program aims to reflect the company's confidence in its lead product candidate PRP, which targets metastatic cancer by ad…

IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain

IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain

IperionX Limited has completed the acquisition of the Camden critical minerals, heavy rare earths, and infrastructure assets adjacent to its Titan Project in Tennessee, expanding its landholdings in the Big Sandy Critical Minerals Province. The acquisition includes approximately 70 acres of ultra-high-grade surface stockpiles and 180 acres of pre-s…

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

Trinity Biotech announced clinical trial results validating its CGM+ wearable biosensor platform’s multi-sensor technology that effectively distinguishes false low glucose readings caused by nocturnal sensor compression from true lows. The data, based on over 5,000 hours of clinical wear, demonstrates improved accuracy and reduced false alarms in c…

Treasure Global Secures Canadian MSB Registration to Accelerate Oxi Wallet’s Global Fintech Expansion

Treasure Global Secures Canadian MSB Registration to Accelerate Oxi Wallet’s Global Fintech Expansion

Treasure Global Inc., a Malaysia-based technology and fintech company listed on NASDAQ, has obtained a Canadian Money Services Business registration. This regulatory milestone enables the company to accelerate the global expansion of its Oxi Wallet digital financial platform, facilitating cross-border payments, remittances, and digital asset transa…

Swarmer, Tekmara and Florida International University Explore Autonomous Drone Swarms for Coastal Restoration and Environmental Monitoring

Swarmer, Tekmara and Florida International University Explore Autonomous Drone Swarms for Coastal Restoration and Environmental Monitoring

Swarmer, Inc. (NASDAQ: SWMR), a drone autonomy software firm known for its combat drone coordination, announced a collaboration with Tekmara and Florida International University to explore using autonomous drone swarms for large-scale environmental monitoring and restoration of coastal habitats such as mangroves and oyster reefs. The partnership wi…

VisionWave Appoints Former UK Member of Parliament Ben Everitt’s Stratonex Defence Technologies as Strategic UK and European Commercialization Partner

VisionWave Appoints Former UK Member of Parliament Ben Everitt’s Stratonex Defence Technologies as Strategic UK and European Commercialization Partner

VisionWave Holdings, Inc. announced a strategic Distributor Agreement with UK-based Stratonex Defence Technologies, co-founded by former UK MP Ben Everitt, to commercialize and integrate VisionWave's advanced defense technologies across the United Kingdom, Europe, and other agreed markets. The partnership aims to enhance VisionWave’s reach in defen…

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

Revolution Medicines announced encouraging Phase 1/2 clinical trial results of its investigational oral RAS(ON) G12D-selective inhibitor zoldonrasib combined with chemotherapy and daraxonrasib for treating patients with metastatic pancreatic ductal adenocarcinoma harboring RAS G12D mutations. The data demonstrated manageable safety profiles and str…

Hudbay Receives Regulatory Approval to Further Increase Mill Throughput at its Constancia Mine in Peru

Hudbay Receives Regulatory Approval to Further Increase Mill Throughput at its Constancia Mine in Peru

Hudbay Minerals Inc. announced that it has obtained approval from Peru's SENACE to amend its environmental permit, allowing an increase in the Constancia mine's mill throughput capacity from 31 million to 34 million tonnes of ore annually. This amendment marks the fifth permit change and supports operational optimization, extended mine life, and im…

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

ZenaTech, Inc., a Nasdaq-listed AI drone technology company, announced its participation in a series of investor and defense industry events across the U.S. and globally. The company aims to showcase its growth in Drone as a Service (DaaS), highlight its subsidiary ZenaDrone's advanced AI-powered drone defense solutions, and build relationships wit…

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical's wholly owned subsidiary Cortigent, Inc. is set to merge with ClearOne, Inc., a Nasdaq-listed company, resulting in a new entity named Cortigent Holdings, Inc. trading under the ticker CRGT. The transaction includes a financing round between $10M and $15M to fund development of Cortigent's neurostimulation brain-computer interface t…

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

YD Bio Limited announced that its U.S. clinical laboratory affiliate, EG BioMed US Inc., has obtained clinical lab licenses in Rhode Island and Pennsylvania, expanding its U.S. lab footprint to 46 states plus DC and Guam. This expansion enhances patient access to early cancer detection tests based on DNA methylation and supports the company's trans…

Eos Energy Announces Commencement of Rights Offering

Eos Energy Announces Commencement of Rights Offering

Eos Energy Enterprises, a U.S.-based developer of zinc-based long duration energy storage systems, has commenced a rights offering to its stock and warrant holders to purchase units consisting of common stock and warrants at $5.481 per unit. The offering aims to raise proceeds to fund a pending investment in Frontier Power USA. The rights and warra…